Type 1 interferons as a potential treatment against COVID-19 - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Antiviral Research Year : 2020

Type 1 interferons as a potential treatment against COVID-19

Abstract

Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinical trials for the treatment of COVID-19.
Fichier principal
Vignette du fichier
S0166354220302059.pdf (180.88 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-02546137 , version 1 (22-08-2022)

Licence

Attribution - NonCommercial

Identifiers

Cite

Erwan Sallard, François-Xavier Lescure, Yazdan Yazdanpanah, France Mentré, Nathan Peiffer-Smadja. Type 1 interferons as a potential treatment against COVID-19. Antiviral Research, 2020, 178, pp.104791. ⟨10.1016/j.antiviral.2020.104791⟩. ⟨inserm-02546137⟩
246 View
43 Download

Altmetric

Share

Gmail Facebook X LinkedIn More